FullPIERS model for predicting adverse maternal outcomes in women with preeclampsia

Published On: 14 Mar, 2024 12:32 PM | Updated On: 14 Mar, 2024 12:45 PM

FullPIERS model for predicting adverse maternal outcomes in women with preeclampsia

Preeclampsia (PE) and various hypertensive disorders complicate approximately 10% of pregnancies globally and pose a significant risk to maternal health. PE is particularly associated with elevated rates of near-miss maternal morbidity and mortality. The Preeclampsia Integrated Estimate of Risk Scoring (PIERS) model helps monitor and stratify risk in women with preeclampsia. The present study assessed adverse maternal outcomes using the fullPIERS risk prediction model in women diagnosed with preeclampsia.

Among the 150 enrolled women with preeclampsia, the fullPIERS score of 35 emerged as the optimal threshold for predicting adverse maternal outcomes. Approximately 36.6% of the women experienced adverse maternal outcomes, including one maternal death. The relative risk for predicting adverse maternal outcomes in women with a fullPIERS score of ≥ 35 was 4.6, and the area under the receiver operating characteristic (ROC) curve was 0.854.

This research underscores that in women diagnosed with preeclampsia, a fullPIERS score of ≥ 35 is significantly associated with adverse maternal outcomes. The findings emphasize the potential utility of the fullPIERS model as a valuable tool for risk assessment and management in this high-risk population.

Sagar U, Singh R, Asnani M, et al. Prediction of adverse maternal outcome in women with preeclampsia using fullPIERS model: observations from a tertiary care hospital. The New Indian Journal of OBGYN.2023;10(1):18-22

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks